[1]
R., P. and M., M. 2025. INVESTIGATION OF LEVOMILNACIPRAN NANOSTRUCTURED LIPID CARRIERS FOR CNS DRUG DELIVERY THROUGH INTRANASAL ADMINISTRATION USING RAT MODEL. International Journal of Applied Pharmaceutics. 17, 5 (Sep. 2025), 343–351. DOI:https://doi.org/10.22159/ijap.2025v17i5.54529.